Neena Bitritto-Garg

Stock Analyst at Deutsche Bank

(2.81)
# 1,766
Out of 4,883 analysts
80
Total ratings
45.76%
Success rate
7.38%
Average return

Stocks Rated by Neena Bitritto-Garg

ACADIA Pharmaceuticals
Feb 11, 2025
Initiates: Hold
Price Target: $22
Current: $20.88
Upside: +5.36%
Roivant Sciences
Apr 3, 2024
Maintains: Buy
Price Target: $14$15
Current: $10.74
Upside: +39.66%
Amylyx Pharmaceuticals
Mar 11, 2024
Maintains: Buy
Price Target: $36$8
Current: $6.76
Upside: +18.34%
Immunovant
Dec 12, 2023
Initiates: Buy
Price Target: $50
Current: $16.43
Upside: +204.32%
Neurocrine Biosciences
Dec 12, 2023
Initiates: Buy
Price Target: $136
Current: $127.88
Upside: +6.35%
COMPASS Pathways
Dec 12, 2023
Initiates: Buy
Price Target: $16
Current: $3.31
Upside: +383.38%
Prothena Corporation
Dec 12, 2023
Initiates: Buy
Price Target: $62
Current: $6.30
Upside: +884.91%
Alector
Dec 12, 2023
Initiates: Buy
Price Target: $12
Current: $1.45
Upside: +727.59%
Sage Therapeutics
Dec 12, 2023
Initiates: Hold
Price Target: $21
Current: $9.16
Upside: +129.38%
Sarepta Therapeutics
Dec 12, 2023
Initiates: Buy
Price Target: $109
Current: $17.32
Upside: +529.33%
Initiates: Buy
Price Target: $8
Current: $1.16
Upside: +592.64%
Maintains: Buy
Price Target: $20$10
Current: $2.75
Upside: +263.64%
Maintains: Buy
Price Target: $7$5
Current: $0.43
Upside: +1,054.73%
Downgrades: Sell
Price Target: $6
Current: $3.71
Upside: +61.73%
Initiates: Buy
Price Target: $21
Current: $3.26
Upside: +544.17%
Initiates: Outperform
Price Target: $23
Current: $96.95
Upside: -76.28%
Initiates: Outperform
Price Target: $36
Current: $23.46
Upside: +53.49%